Paper Details

  1. Home
  2. Paper Details

Naltrexone/bupropion: an investigational combination for weight loss and maintenance.

Author: GwinnKatherine M, HurrenKathryn M, MakowskiCharles T

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Naltrexone/bupropion, an investigational combination therapy, resulted in significant weight loss and improvement in various metabolic parameters, including HbA1c, in obese patients with comorbid conditions.
Paper Details　
Original Abstract of the Article :
Naltrexone/bupropion is an investigational combination for weight loss and maintenance in patients who are obese or have a BMI ≥ 27 kg/m(2) with comorbid diabetes, hypertension or hyperlipidemia. Pooled results from four phase 3 trials reveal placebo-subtracted mean weight loss of 4.7% (range 3.2-5....See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444555/

データ提供：米国国立医学図書館（NLM）

Naltrexone/bupropion: A New Hope for Weight Management

Obesity is a growing concern, affecting millions worldwide. It's like a desert that is slowly consuming everything in its path. This study investigated the effectiveness of naltrexone/bupropion, a combination medication, for weight loss and maintenance in individuals with obesity or a high body mass index (BMI). The researchers found that this combination therapy was associated with significant weight loss, improvements in metabolic parameters, and improved quality of life.

A Promising Combination for Weight Loss

The study demonstrated that naltrexone/bupropion significantly reduced weight in obese patients. This was a substantial finding, as it indicated a potential new approach for managing obesity. The combination therapy also improved various metabolic markers, such as triglycerides, high-density lipoprotein, and fasting insulin. This suggests that naltrexone/bupropion could have a positive impact on overall health, not just weight loss. The study found that naltrexone/bupropion achieved a placebo-subtracted mean weight loss of 4.7% after one year. This is like transforming a barren desert into a fertile oasis.

A Brighter Future for Weight Management

This research suggests that naltrexone/bupropion could be a valuable tool for managing obesity and its associated metabolic complications. By providing a safe and effective option for weight loss and maintenance, this combination therapy could improve the lives of millions of people struggling with obesity. The study results offer a glimmer of hope in the fight against this global health challenge, potentially leading to a brighter future for weight management.

Dr.Camel's Conclusion

This study demonstrates the potential of naltrexone/bupropion as a promising treatment option for weight management. It offers hope for a future where obesity can be better managed, leading to improved health outcomes and a better quality of life for individuals affected by this condition.

Date :
  1. Date Completed 2012-06-06
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

22249001

DOI: Digital Object Identifier

PMC6444555

Related Literature

Article Analysis
・Side Effects of naltrexone and bupropion
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.